PRF1 and neoplasm: Effector CD8+ T cells, also named cytotoxic T lymphocytes (CTL), play the most significant adaptive tumor-killing effects in TME by releasing cytotoxic perforins, granzymes, and cytokines such as interferon (IFN)-γ and tumor necrosis factor-α (8).